Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG Induction in NHB Renal Transplant
NCT00733733Phase 3Unknown
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2008
- Primary completion
- Jan 2010
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of grafalon in kidney transplantation (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Incidence of initial delayed graft function at 3 months. Status: unknown.
02
Drugs
grafalon
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00733733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00733733.